Exploristics provides innovative analysis solutions to extract information from your clinical data.  We support the design and analysis of a broad range of clinical research studies.  We have unique expertise in the exploratory analysis and clinical application of high-dimensional data including Biomarkers, Pharmacogenomics, Imaging and Observational data.  We collaborate with Pharmaceutical, Biotechnology, Medical Diagnostics and Devices Companies as well as Healthcare Providers.

Exploristics offer more than a statistical analysis and reporting service.  We take pride in using our analytical skills and scientific expertise to help you make informed decisions across drug discovery and clinical development.  We aim to work with you to understand your data analysis needs and to provide practical solutions to your problems.  Our service is friendly and cost-effective and our work is compliant with GCP/ICH guidelines.

 Join our expanding group of satisfied clients and contact us today!

Drug Regulators are now requesting the collection of blood samples for Pharmacogenetics research as part of clinical development programs. We work with customers to help them discover and exploit the PGx opportunities within their development portfolio.

Our services are tailored to address your specific needs.

        » Consultancy
        » Data Exploration
        » Experimental Design
        » Modeling and Simulation
        » In-licensing opportunities
        » Pharmacogenomics
        » Biomarker Analysis
        » Predictive Modeling
        » Training and Education

Many clinical studies collect data on numerous biomarkers but have difficulty in finding a group with the expertise to perform the analysis for all of these data.  We give you a consistent, integrated analysis that can be interpreted and integrated into your development programs.

There is increasing interest in the Pharmaceutical industry to find other more sensitive endpoints than those accepted currently by regulators. We have helped to design and analyse studies into imaging modalities to compare new endpoints with traditional measures.

We have experience in analysing observational data from large healthcare databases and medical claims data. These data have a broad range of applications such as the identification of new indications for medications, concomitant medications, co-morbidities and the estimation of adverse event rates.